147 related articles for article (PubMed ID: 16970392)
1. Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.
Sagara Y; Sagara T; Uchiyama M; Otsuki S; Kimura T; Fujikawa T; Noguchi K; Ohtake N
J Med Chem; 2006 Sep; 49(19):5653-63. PubMed ID: 16970392
[TBL] [Abstract][Full Text] [Related]
2. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).
Peretto I; Forlani R; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Bigogno C; Misiano P; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Delcanale M; Salcedo C; Fernández AG; Imbimbo BP
J Med Chem; 2007 Apr; 50(7):1571-83. PubMed ID: 17352462
[TBL] [Abstract][Full Text] [Related]
3. Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.
Sagara Y; Sagara T; Mase T; Kimura T; Numazawa T; Fujikawa T; Noguchi K; Ohtake N
J Med Chem; 2002 Feb; 45(4):984-7. PubMed ID: 11831911
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.
Lainé DI; McCleland B; Thomas S; Neipp C; Underwood B; Dufour J; Widdowson KL; Palovich MR; Blaney FE; Foley JJ; Webb EF; Luttmann MA; Burman M; Belmonte K; Salmon M
J Med Chem; 2009 Apr; 52(8):2493-505. PubMed ID: 19317446
[TBL] [Abstract][Full Text] [Related]
5. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).
Peretto I; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Cerri A; Menegon S; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Bassani F; Delcanale M; Imbimbo BP
J Med Chem; 2007 Apr; 50(7):1693-7. PubMed ID: 17352463
[TBL] [Abstract][Full Text] [Related]
6. In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice.
Yamada S; Maruyama S; Takagi Y; Uchida S; Oki T
Life Sci; 2006 Dec; 80(2):127-32. PubMed ID: 16996089
[TBL] [Abstract][Full Text] [Related]
7. M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.
Budzik B; Wang Y; Shi D; Wang F; Xie H; Wan Z; Zhu C; Foley JJ; Nuthulaganti P; Kallal LA; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Laine DI; Jin J
Bioorg Med Chem Lett; 2009 Mar; 19(6):1686-90. PubMed ID: 19243945
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonists.
Kumar N; Kaur K; Aeron S; Dharmarajan S; Silamkoti AD; Mehta A; Gupta S; Chugh A; Gupta JB; Salman M; Palle VP; Cliffe IA
Bioorg Med Chem Lett; 2007 Sep; 17(18):5256-60. PubMed ID: 17629699
[TBL] [Abstract][Full Text] [Related]
11. 1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.
Sonda S; Katayama K; Fujio M; Sakashita H; Inaba K; Asano K; Akira T
Bioorg Med Chem Lett; 2007 Feb; 17(4):925-31. PubMed ID: 17188867
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
[TBL] [Abstract][Full Text] [Related]
13. Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.
Varoli L; Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Bedini A; Fazio N; Spampinato S
Bioorg Med Chem Lett; 2008 May; 18(9):2972-6. PubMed ID: 18395442
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
[TBL] [Abstract][Full Text] [Related]
16. J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors.
Mitsuya M; Mase T; Tsuchiya Y; Kawakami K; Hattori H; Kobayashi K; Ogino Y; Fujikawa T; Satoh A; Kimura T; Noguchi K; Ohtake N; Tomimoto K
Bioorg Med Chem; 1999 Nov; 7(11):2555-67. PubMed ID: 10632066
[TBL] [Abstract][Full Text] [Related]
17. 1,4-dioxane, a suitable scaffold for the development of novel M₃ muscarinic receptor antagonists.
Del Bello F; Barocelli E; Bertoni S; Bonifazi A; Camalli M; Campi G; Giannella M; Matucci R; Nesi M; Pigini M; Quaglia W; Piergentili A
J Med Chem; 2012 Feb; 55(4):1783-7. PubMed ID: 22243489
[TBL] [Abstract][Full Text] [Related]
18. Lead generation using pharmacophore mapping and three-dimensional database searching: application to muscarinic M(3) receptor antagonists.
Marriott DP; Dougall IG; Meghani P; Liu YJ; Flower DR
J Med Chem; 1999 Aug; 42(17):3210-6. PubMed ID: 10464008
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
[TBL] [Abstract][Full Text] [Related]
20. CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives.
Imamura S; Nishikawa Y; Ichikawa T; Hattori T; Matsushita Y; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
Bioorg Med Chem; 2005 Jan; 13(2):397-416. PubMed ID: 15598561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
